Plasma Protein Binding Assay Market

Plasma Protein Binding Assay is an assay, or an analytic procedure, whose procedure or method relies on the binding of ligand molecules to receptors, antibodies or other macromolecules.[1] A detection method is used to determine the presence and extent of the ligand-receptor complexes formed, and this is usually determined electrochemically or through a fluorescence detection method.[2] This type of analytic test can be used to test for the presence of target molecules in a sample that are known to bind to the receptor.

Plasma Protein Binding Assay Market contains market size and forecasts of Plasma Protein Binding Assay in Global, including the following market information:

• Global Plasma Protein Binding Assay Market Revenue, 2017-2022, 2023-2028, ($ millions)
• Global top five companies in 2021 (%)

The global Plasma Protein Binding Assay market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Equillibrium Dialysis Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Plasma Protein Binding Assay include 3B Pharmaceuticals, Absorption Systems, Admecell, Biotium, Danaher Corporation, Eurofins Scientific, GE Healthcare, Htdialysis and Merck, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Plasma Protein Binding Assay companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Plasma Protein Binding Assay Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Plasma Protein Binding Assay Market Segment Percentages, by Type, 2021 (%)

• Equillibrium Dialysis
• Ultrafiltration
• Ultracentrifugation
• Gel Filtration Chromatography

Global Plasma Protein Binding Assay Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Plasma Protein Binding Assay Market Segment Percentages, by Application, 2021 (%)

• Pharmaceutical & Biotechnology Companies
• Contract Research Organization

Global Plasma Protein Binding Assay Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Plasma Protein Binding Assay Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

• Key companies Plasma Protein Binding Assay revenues in global market, 2017-2022 (estimated), ($ millions)
• Key companies Plasma Protein Binding Assay revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• 3B Pharmaceuticals
• Absorption Systems
• Admecell
• Biotium
• Danaher Corporation
• Eurofins Scientific
• GE Healthcare
• Htdialysis
• Merck
• Sovicell GmbH
• Thermo Fisher Scientific